SCHEMBL24601429

SCHEMBL24601429

C[C@@H](CC(=O)O)c1cc2cc(NC(=O)c3ccccc3)ccc2s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.59
PDGFRB P09619 3/20 0.49
KDR P35968 3/20 0.49
CASP3 P42574 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
NPC1 O15118 7/20 0.49
RAB9A P51151 7/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
HTT P42858 3/20 0.49
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 2/20 0.44
PSMB8 P28062 1/20 0.44
KCNK3 O14649 1/20 0.44
KCNK9 Q9NPC2 1/20 0.44
MAPT P10636 3/20 0.44
ACE2 Q9BYF1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601427 0.87 MAPT (0.53) HDAC1PDGFRBKDRCASP3SENP8
SCHEMBL24601446 0.76 HDAC1 (0.66) HDAC1PDGFRBKDRNPC1RAB9A
SCHEMBL15697580 0.76 HDAC1 (0.82) HDAC1PDGFRBKDRNPC1RAB9A
SCHEMBL1886609 0.75 HDAC1 (1.00) HDAC1PDGFRBKDR
SCHEMBL15697561 0.74 HDAC1 (0.74) HDAC1PDGFRBKDRNPC1RAB9A
SCHEMBL1885247 0.73 HDAC1 (0.68) HDAC1PDGFRBKDRNPC1RAB9A
SCHEMBL13709530 0.72 HDAC1 (0.74) HDAC1PDGFRBKDRNPC1RAB9A
SCHEMBL22746587 0.71 KCNK3 (0.51) HDAC1PDGFRBKDRNPC1RAB9A
SCHEMBL22718596 0.70 HDAC1 (0.46) HDAC1CASP3SENP8SENP7SENP6
SCHEMBL30369793 0.69 RAB9A (0.81) HDAC1CASP3SENP7NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213052-A1 INHIBITORS OF RNA-BINDING PROTEINS, COMPOSITIONS THEREOF, AND THERAPEUTIC USES THEROF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213052-A1 INHIBITORS OF RNA-BINDING PROTEINS, COMPOSITIONS THEREOF, AND THERAPEUTIC USES THEROF HNRNPF, RBM3, RBM15 HDAC1 1875/4885PDGFRB 3384/4885KDR 3374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.